Soluble PD-L1 as an early marker of progressive disease on nivolumab

by Choueiri, T.K, Freeman, G.J, Mahoney, K.M, Mcdermott, D.F, Ross-Macdonald, P., Song, L., Stephen Hodi, F., Veras, E., Wind-Rotolo, M., Yuan, L.
Published 2022

The Programmed Death-1 Pathway Counter-Regulates Inflammation-Induced Osteoclast Activity in Clinical and Experimental Settings

by Deleuran, B., Freeman, G.J, Greisen, S.R, Hauge, E.M, Hetland, M.L, Hørslev-Pedersen, K., Hvid, M., Junker, P., Kragstrup, T.W, Moestrup, S.K, Ørnbjerg, L., Østergaard, M., Sharpe, A.H, Stengaard-Pedersen, K., Thomsen, J.S
Published 2022

Anti-CAIX BBζ CAR4/8 T cells exhibit superior efficacy in a ccRCC mouse model

by Bonal, D.M, Buck, A., Choueiri, T.K, Culhane, A.C, Freeman, G.J, Grimaud, M., Huang, Y., Kodangattil, S., Marasco, W.A, Nguyen, Q.-D, O'Donnell, M.L, Razimbaud, C., Signoretti, S., Wang, Y., Wei, K., Zhu, Q., Zhu, Z.
Published 2022